
Midatech Pharma plc MTP
Annual report 2024
added 03-21-2026
Midatech Pharma plc Operating Cycle 2011-2026 | MTP
Annual Operating Cycle Midatech Pharma plc
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 245 | 3.37 K | - | - | - | - |
All numbers in GBP currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.37 K | 245 | 1.81 K |
Operating Cycle of other stocks in the Biotechnology industry
| Issuer | Operating Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
MediWound Ltd.
MDWD
|
78.7 | $ 17.08 | 2.83 % | $ 465 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
237 | $ 19.7 | 2.44 % | $ 921 M | ||
|
Mesoblast Limited
MESO
|
0.01 | $ 15.54 | 8.48 % | $ 10.1 B | ||
|
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
BeiGene, Ltd.
BGNE
|
52.6 | - | 0.49 % | $ 251 B | ||
|
Mirum Pharmaceuticals
MIRM
|
70.6 | $ 90.9 | 3.44 % | $ 4.56 B | ||
|
bluebird bio
BLUE
|
127 | - | - | $ 546 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Cara Therapeutics
CARA
|
52.4 | - | -3.03 % | $ 260 M | ||
|
Advaxis
ADXS
|
88.1 | - | -9.65 % | $ 45.9 M | ||
|
CytomX Therapeutics
CTMX
|
12.2 | $ 4.41 | 3.98 % | $ 608 M | ||
|
Cyclacel Pharmaceuticals
CYCC
|
185 | - | -5.98 % | $ 34.1 M | ||
|
ChemoCentryx
CCXI
|
3.1 | - | - | $ 3.74 B | ||
|
Merck & Co.
MRK
|
204 | $ 118.9 | 2.17 % | $ 297 B | ||
|
Dynavax Technologies Corporation
DVAX
|
512 | - | - | $ 2.02 B | ||
|
BioDelivery Sciences International
BDSI
|
436 | - | -4.8 % | $ 255 M | ||
|
Neurocrine Biosciences
NBIX
|
517 | $ 131.82 | 3.1 % | $ 13.1 B | ||
|
Arbutus Biopharma Corporation
ABUS
|
50 | $ 4.56 | 5.68 % | $ 874 M | ||
|
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M |